- Home
- DXR vs CNF Comparison
DXR vs CNF Comparison
Compare DXR & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXR
- CNF
- Stock Information
- Founded
- DXR 1970
- CNF 1999
- Country
- DXR United States
- CNF China
- Employees
- DXR N/A
- CNF N/A
- Industry
- DXR Medical/Dental Instruments
- CNF Finance: Consumer Services
- Sector
- DXR Health Care
- CNF Finance
- Exchange
- DXR Nasdaq
- CNF Nasdaq
- Market Cap
- DXR 36.4M
- CNF 34.1M
- IPO Year
- DXR N/A
- CNF 2018
- Fundamental
- Price
- DXR $9.75
- CNF $0.64
- Analyst Decision
- DXR Strong Buy
- CNF
- Analyst Count
- DXR 1
- CNF 0
- Target Price
- DXR $25.00
- CNF N/A
- AVG Volume (30 Days)
- DXR 5.6K
- CNF 301.2K
- Earning Date
- DXR 01-01-0001
- CNF 04-30-2025
- Dividend Yield
- DXR N/A
- CNF N/A
- EPS Growth
- DXR 86.16
- CNF N/A
- EPS
- DXR 0.11
- CNF 0.08
- Revenue
- DXR $119,714.00
- CNF $85,661,735.00
- Revenue This Year
- DXR N/A
- CNF $252.34
- Revenue Next Year
- DXR N/A
- CNF N/A
- P/E Ratio
- DXR $84.18
- CNF $8.31
- Revenue Growth
- DXR N/A
- CNF N/A
- 52 Week Low
- DXR $6.55
- CNF $0.37
- 52 Week High
- DXR $10.00
- CNF $2.84
- Technical
- Relative Strength Index (RSI)
- DXR 69.88
- CNF 57.37
- Support Level
- DXR $8.68
- CNF $0.42
- Resistance Level
- DXR $9.03
- CNF $0.77
- Average True Range (ATR)
- DXR 0.47
- CNF 0.08
- MACD
- DXR 0.03
- CNF 0.02
- Stochastic Oscillator
- DXR 90.38
- CNF 54.29
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
About CNF CNFinance Holdings Limited each representing twenty (20)
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, it has an operation in PRC.